Updates | Elegaiter

Elegaiter Updates

Check out ourlatest updates

Elegaiter has obtained domestic and international certifications and patents.

Check out our news, papers, and patents.

2026-10-29

CiKLux Discusses Clinical Applications of Elegaiter with EUMC

On October 29, CiKLux held an advisory meeting with Professor Junwoo Byun of the Department of Orthopedic Surgery at the Open Lab of Ewha Womans University Mokdong Hospital to discuss how Elegaiter can be used in clinical settings. CEO Hyunsang Cho and Assistant Manager Kyungju Ahn attended for CiKLux, joined by Professor Byun, Open Lab Team Leader Kyungtae Park, and other hospital staff. CiKLux introduced Elegaiter’s non-wearable, effortless gait analysis method, which measures motor current by connecting to a treadmill’s power supply. The team explained that it can observe dynamic gait patterns over long sessions of 10 minutes to an hour, and shared real pattern cases such as leg length discrepancy, fractures, disc conditions, and age-related muscle loss. The meeting helped clarify the role Elegaiter can play in healthcare. Participants agreed that Elegaiter is better suited to screening before hospital visits and to following up with patients in daily life than to in-hospital diagnosis. Professor Byun noted that tracking functional recovery, such as regaining muscle strength after surgery, in sports injury patients would be clinically meaningful. If left-right differences in the gait graph can show recovery relative to the uninjured leg, Elegaiter could offer a new way to monitor strength recovery every day, something that is difficult to do in a hospital. The two sides also outlined a validation roadmap. To build credibility, external validation showing that Elegaiter works objectively across many subjects was emphasized. The plan is to move step by step from a small pilot test to IRB approval and then to an investigator-initiated trial (IIT). CiKLux will share its study design for Professor Byun’s review and, in November and December, will run a validation comparing smartphone camera-based gait analysis with Elegaiter data. CiKLux also proposed joint research toward a publication. CiKLux is developing Elegaiter, its own AIoT-based gait digital healthcare service, while steadily building clinical evidence through collaboration with medical experts. We will continue to share expertise and keep innovating, so that we can grow as a reliable partner alongside the bio and healthcare industry. Thank you.

2026-10-23

Listening to Our First Customer: CiKLux Visits Danaagym in Changwon

On October 23, CiKLux visited Danaagym, an exercise rehabilitation center in Changwon, Korea, for a meaningful meeting with its director, Jeonghoon Lee. CEO Hyunsang Cho and Assistant Manager Kyungju Ahn joined the visit. The team heard firsthand how the center has been using JAWS, Elegaiter’s gait analysis device, and provided on-site support so the center could get the most out of it in daily operations. This visit held special meaning for our team. Danaagym was the very first customer to purchase Elegaiter after we launched our Naver Smart Store. Director Lee discovered Elegaiter through the running-content Instagram account that our Saessak Team 2 has been carefully building. The content our team members created turned into a connection with our first customer. Director Lee highlighted JAWS’s biggest strength: compared with high-end gait and dynamic analysis equipment, it lets users check the actual load during walking at an affordable price. The center currently uses it to check left-right balance in members who are new to treadmills and to analyze runners’ posture and balance. During the visit, our team checked how JAWS connects with the center’s treadmill, optimized the measurement settings, and showed staff how to read the gait graphs and use the game mode. The conversation was also full of ideas from the field. Director Lee suggested showing on a graph how gait differs when holding the treadmill handrails compared with walking properly. He also proposed tracking gait habits that linger after rehabilitation to help prevent pain from coming back. These suggestions from a rehabilitation professional offered valuable inspiration for Elegaiter’s future development. The two organizations also agreed to work together on data: Danaagym will tag members’ gait reports with key details such as pain areas, and CiKLux will provide additional interpretation based on the accumulated data. CiKLux is developing Elegaiter, its own AIoT-based gait digital healthcare service, while listening closely to voices from the field and building the service together with its customers. We will continue to work closely with partners in the field and keep innovating, so that we can be a reliable partner in helping more people walk healthier. Thank you.

2026-10-23

CiKLux Visits JOABRO’s Gimhae Branches to Strengthen Collaboration

On October 23, CiKLux visited JOABRO’s branches in Gimhae to check on-site conditions and discuss ways to work together. JOABRO runs a conditioning platform and fitness centers, and has been a trusted partner of CiKLux for nearly a year. CEO Hyunsang Cho and Assistant Manager Kyungju Ahn made the visit. They delivered the JAWS gait analysis devices for Elegaiter that JOABRO purchased to its Busan and Gimhae branches, and took a close look at how the devices will be used in daily operations. The team also tested how gait patterns are measured on DRAX MyMountain equipment, as part of our effort to expand Elegaiter beyond standard treadmills to a wider range of exercise equipment. The visit also led to an important discovery that could only be made in the field. When two treadmills fitted with JAWS were plugged into a single power strip connected to one outlet and run at the same time, electrical interference distorted the gait data waveforms. The high power draw of the 1 kW treadmill appears to be the cause. As a first step, we will put analysis devices on a dedicated power source. We also plan to create a standard installation and operation guide that accounts for each center’s electrical setup. We are glad to have found this improvement point before expanding to more centers. The two companies also held in-depth discussions on Center Mode and Trainer Mode. JOABRO participates in the Open Lab program at Pusan National University Yangsan Hospital and signed a service contract with CiKLux, through which these two features were developed. Center Mode helps a center manage gait data for many members efficiently, and Trainer Mode lets trainers record and manage feedback and comments for each member. The companies discussed how to bring these features into real center operations and expand them into personalized care programs based on gait analysis. CiKLux is developing Elegaiter, its own AIoT-based gait digital healthcare service, while testing and refining the service in the field together with its partners. We will continue to work closely with partners in the field and keep innovating, so that we can grow as a reliable partner alongside the bio and healthcare industry. Thank you.

2026-09-20

Elegaiter Proves Value at 'PCA KOREA SUPER SERIES'

The 'PCA KOREA SUPER SERIES', one of the largest fitness competitions in South Korea, was successfully held over two days from September 19th to 20th. During the event, our Elegaiter team co-operated the 'Elegaiter Gait Analysis Booth' in collaboration with 'Joabro Conditioning'. It was a deeply meaningful opportunity to directly connect with fitness professionals and experts—the primary target audience for our product—and listen closely to their vivid, firsthand voices. This field participation was particularly significant as it allowed us to identify the critical need among fitness center operators for increasing the average sales per customer (unit price), while offering a clear, data-driven solution. By shifting away from traditional methods that rely heavily on a trainer's subjective assessment, Elegaiter visualizes and proves a member's movements through quantitative data. This experience has strengthened our confidence that fitness centers can successfully market their programs as premium services. Numerous industry insiders who visited our booth deeply resonated with the necessity of data-driven consultation and expressed overwhelming interest. While continuously advancing Elegaiter, our proprietary AIoT-based digital gait healthcare service, CiKLux is also preparing for the upcoming Wadiz crowdfunding campaign set to open at the end of September. As a special reward, we plan to provide close, customized support for the initial backers by implementing the specific gait analysis features and service developments they desire over a three-month period. Moving forward, we remain committed to technological innovation that listens to the voices on the ground, establishing ourselves as the most reliable partner growing alongside the fitness and healthcare industries. Thank you.

2026-09-16

CEO Invited as an Official Lecturer at 'Biohealth Academy'

## [Company News] CEO Hyun-sang Cho Invited as an Official Lecturer at the Chungbuk Bio-humanities and Academic Convergence Institute's 'Biohealth Academy' From September 16th to 17th, the ‘Biohealth Regulation and Licensing Practical Training: Clinical Trial Design and Major Considerations for Commercializing Pharmaceuticals, Medical Devices, and Digital Medical Products’ course was successfully conducted as part of the 'Biohealth Academy' program hosted by the Chungbuk Bio-humanities and Academic Convergence Institute. For this training course, Hyun-sang Cho, CEO of CiKLux, was invited as an official lecturer to pass down in-depth practical know-how to biohealth majors and prospective job seekers looking to enter the industry. CEO Hyun-sang Cho focused heavily on clinical trial design strategies indispensable for successfully commercializing not only conventional pharmaceuticals and medical devices but also digital medical products—a major hot topic in the current market. Rather than leaning on abstract theories, he generously shared core field-driven considerations that can be applied immediately in the industry, receiving highly enthusiastic responses from the trainees. Trainees who participated in the session sent expressions of gratitude, stating, "Being exposed to such specific, professional guides that can be put to work right in the field was incredibly helpful for our future career development." We send our most sincere encouragement to all the trainees who are passionately undergoing this extensive training curriculum to become the next leaders of the biohealth industry. We genuinely bless each of you, hoping that the knowledge and practical wisdom gained during these two days will serve as a fertile foundation to achieve your dreams and grow into brilliant assets to the bio sector. CiKLux develops its proprietary AIoT-based gait digital healthcare service, Elegaiter, while simultaneously taking dedicated steps to nurture global and domestic clinical trial experts, providing unsparing support so that our industry and its members can grow together. We will continue to be a dependable partner, advancing alongside the bio and healthcare industries through professional knowledge sharing and continuous technological innovation. Thank you.

2026-09-15

CEO Takes the Stage! '2026 NextBio Scale-up Academy'

Hyun-sang Cho, CEO of CiKLux, was invited as a keynote speaker and delivered a lecture at the '2026 NextBio Scale-up Academy (BioBiz Jumpstart)' on September 15. In this program designed to support the growth of startups in the bio and medical sectors, CEO Cho presented on the topic of "Understanding the Full Lifecycle of Digital Healthcare Development." The lecture provided a clear overview of core practical processes that digital healthcare companies frequently find challenging, including product planning, software (SW) development, SaMD (Software as a Medical Device) classification, clinical validity verification using algorithms and RWE (Real-World Evidence), and regulatory approval procedures. CEO Cho is a recognized clinical trial expert who continuously leads educational sessions for various specialized institutions, including clinical training programs for the Korea National Enterprise for Clinical Trials (KONECT). His lecture at this event once again demonstrated CiKLux’s industry-leading expertise, drawing significant engagement from biotech professionals in attendance. 'Elegaiter', the gait analysis and exercise solution service currently being advanced by the CiKLux team, is being developed based on this comprehensive expertise that spans from initial clinical planning to validation and regulatory approval. Leveraging its specialized technical capabilities and industry knowledge, CiKLux plans to further refine Elegaiter's features to deliver a highly sophisticated service to the clinical trial market. We look forward to the continued interest and support of our customers and partners.

2026-09-14

Our Journey to the 2nd Round Presentation

Elegaiter, the new product currently under development by CiKLux, has completed its Phase 2 face-to-face presentation evaluation, marking the final stage of the '2026 AI Small Business Innovation Support Program'. The program saw intense competition in the initial phase, recording a high 12:1 ratio for the Phase 1 document screening. Having successfully advanced, CiKLux's CEO took the stage as the primary presenter for the Phase 2 evaluation, presenting the company's technical capabilities as a specialized clinical research organization (CRO) alongside the market potential of the product. The presentation was delivered strictly within the 10-minute time limit. While the panel of judges raised highly technical and sharp questions, the session served as an opportunity to objectively demonstrate Elegaiter’s technological value and distinct advantages through clear, expertise-backed responses. Members of the internal team present at the site were able to reconfirm the core competitiveness and value of our product. Upon final selection for this support program, the secured resources will be fully allocated toward advancing Elegaiter’s service capabilities and executing aggressive marketing campaigns for market entry. This initiative is expected to elevate the product as a driver of digital transformation in the clinical trial market while significantly broadening touchpoints with partners and clients. Having successfully navigated both the competitive document screening and the critical face-to-face evaluation, the entire team now awaits a positive final outcome. We appreciate the continued interest and support from our employees and partners as Elegaiter prepares for its next milestone. Further updates will be shared as soon as the final results are announced.

2026-09-09

Meeting Elegaiter’s Future at 'Try Everything 2026'

[Seoul DDP = CiKLux Newsroom] The CiKLux team, developers of the gait analysis and exercise solution service 'Elegaiter', visited the Dongdaemun Design Plaza (DDP) to participate in 'Try Everything 2026', Seoul's premier startup festival in September, actively seeking to discover new partner firms. During the event, the CiKLux team held consecutive 30-minute, close-knit 1:1 business meetings with representatives from major public institutions and large enterprises. This provided a significant opportunity to widely introduce the core technological capabilities and clinical value of their new product, Elegaiter, ahead of its market launch later this year, while actively seeking reliable partners to create strategic synergies. Notably, this year's DDP event combined tech demonstrations for startups with various cultural and entertainment elements, including an appearance by the globally rising virtual idol group 'PLAVE', adding to the vibrancy of the festival. An internal representative present at the site noted that the business trip served as a multifaceted opportunity to achieve core promotional goals while directly experiencing the latest cultural trends and gaining broader market insights. Leveraging the active partnerships forged with major enterprises and institutions during this event, CiKLux plans to diversify Elegaiter's distribution channels and aggressively expand its market share in the coming months.

2026-08-21

CiKLux Successfully Concludes 'KHF 2026' Exhibition via Ewha Medical Center Joint Pavilion, Drawing Immense Interest for AIoT Gait Wellness Solution 'Elegaiter'

• Selected as an enterprise by the Ewha Medical Center Open Innovation Lab to showcase at COEX 'KHF 2026' • 'Elegaiter,' newly launched this past July, offered live trials to over 50 visitors, providing real-time gait monitoring reports • Accurately detected gait imbalances across all age groups (10s to 80s); accelerated cross-industry partnership discussions for original technology [COEX, Seoul = CiKLux Newsroom] CiKLux, an AIoT-based digital healthcare startup, announced the successful wrap-up of its live demonstration and exhibition for 'Elegaiter,' a trailblazing gait wellness solution, at the K-HOSPITAL+HEALTH TECH FAIR 2026 (KHF 2026) held at COEX, Seoul, from August 19 to 21. CiKLux participated in this premier domestic digital healthcare exhibition as a selected promising enterprise of the Ewha Medical Center Open Innovation Lab. The company occupied a prominent space within the 'Hospital R&D Innovation Zone,' which showcases achievements bridged between clinical infrastructure and startup commercialization. The on-site booth experienced an enthusiastic response. Over the three-day event, more than 50 attendees—ranging in age from teenagers to octogenarians—experienced the Elegaiter system firsthand by walking on a treadmill for just 3 minutes. Powered by its patented original technology 'JAWS,' Elegaiter is an innovative AIoT solution that analyzes the instantaneous power consumption of a treadmill's motor to track walking balance and risk signals in real-time, eliminating the need for cumbersome wearables or cameras. Participants expressed immense fascination upon receiving their customized 'Real-Time Gait Monitoring Report' generated immediately after the trial. The system dynamically captured underlying physical imbalances with precision: for instance, it visually graphed the compromised walking symmetry of a user with a past torn meniscus, and vividly highlighted a 2-degree rightward lateral tilt in another user's posture alignment. On-site trial participants remarked, "It is incredibly fascinating to see hidden musculoskeletal instability and gait imbalances translated into intuitive, real-time visual data right before our eyes." Furthermore, KHF 2026 served as a high-value networking hub that underscored the infinite cross-industry scalability of CiKLux's core technology. The booth hosted successive strategic meetings with prospective partner companies from fields that initially seemed unrelated, including fitness centers, senior care (dementia prevention), education, and insurance. The discovery of synergistic pathways to repurpose and integrate the raw data analytics into diverse service models yielded highly encouraging results. "Following our official market launch this past July, we are thrilled that Elegaiter has gained such profound public interest and clinical validation at KHF 2026," said Hyunsang Cho, CEO of CiKLux. "We remain committed to transforming repetitive treadmill workouts into engaging, personalized wellness content. Moving forward, we will actively accelerate open innovation partnerships both domestically and globally to expand daily gait analytics into comprehensive preventative healthcare.

Updates CiKLux Successfully Concludes 'KHF 2026' Exhibition via Ewha Medical Center Joint Pavilion, Drawing Immense Interest for AIoT Gait Wellness Solution 'Elegaiter' image

2026-08-10

Visit Us at KHF 2026: Booth F50

We are pleased to introduce our core technology, CiKLux Elegaiter, at the K-Hospital Fair 2026 (KHF 2026) from August 19th to 21st at COEX. You can visit our exhibition at Booth F50, hosted within the Ewha Womans University Mokdong Hospital Open Laboratory Joint Pavilion. Presenting our hard work alongside leading healthcare pioneers at this prestigious event fills our team with immense excitement and a strong sense of purpose. At this year's exhibition, we will showcase the foundational data and hardware versatility of Elegaiter, which is currently undergoing real-world application across fitness networks like Joabro Fitness. We look forward to connecting with digital health software developers who can transform our tracking data into clinical evidence, and hospital officials interested in exploring new possibilities for smart rehabilitation and wellness infrastructure. Free pre-registration is available until August 18th, so please secure your complimentary pass before the deadline. • Event: K-Hospital Fair 2026 (KHF 2026) • Date: 10:00 – 18:00 August 19 (Mon) – August 21 (Wed), 2026 (※ Closes at 17:00 on Friday) • Location: 3th floor C, D hall COEX, Seoul, https://linkonbiz.com/product/14788 • Booth Number: F50 Ewha Womans University Mokdong Hospital Open Lab Joint Pavilion • Free Pre-registration by Tuesday, August 18th https://khospital.org/registration/#/pre-reg/891 Thank you.

2026-08-05

📢 Hey Tired Office Workers! 'Elegaiter' Now on Naver Smart Store (feat. KHF Special Offer) 💥

Do you find yourself collapsing onto the couch right after work? 🙋‍♀️ We totally get it—you know you need to work out, but even breathing feels like a chore when you're exhausted. After burning out completely at the office today, you might ask, "Who's gonna take care of my body?" Don't worry, Elegaiter will take care of you! 🐊✨ (It sounds like an alligator, but it's actually your ultimate body caretaker!) Now you can easily purchase Elegaiter on the Naver Smart Store! To celebrate the launch and the KHF period from August 19th to 21st, we are running an exclusive, limited-time additional discount. Don't miss this chance to invest in your wellness! Search 'Elegaiter JAWS' on Naver to shop right now! #ciklux #elegaiter #NaverSmartStore #OfficialLaunch #ShopNow #NewArrival #Kbeauty #TrendingItem #KHF2026 #OfficeWorkerLife #BurnoutCure #LimitedTimeOffer #ShopNow #SelfCare

2026-08-03

Lectured at 2026 2nd KoNECT CRA Introductory Practical Training Course

From August 3rd to 7th, the "2026 2nd Clinical Research Associate (CRA) Introductory Practical Training Course" hosted by the Korea National Enterprise for Clinical Trials (KoNECT) was successfully conducted. Continuing from the previous sessions, CiKLux's very own CEO Hyunsang Cho, along with Senior Vice President Sung-eun Kim and Director Seon-nyeo Lee, were invited as official lecturers to share their extensive real-world expertise. This second session held an incredibly special meaning for our team. A new CiKLux team member—who actually completed the 1st session of this exact same course back in February and subsequently joined our company—participated in this session as an assistant lecturer. During the highly challenging yet critical EMR (Electronic Medical Record) review and SDV (Source Data Verification) practical sessions, our team member provided close support to the new trainees, sharing fresh insights and empathetic guidance from the perspective of someone who was recently in their exact same shoes. While building and expanding our AIoT-based digital gait healthcare platform, Elegaiter, CiKLux Inc. remains deeply committed to advancing professional clinical research ecosystems and fostering the growth of our talented team members.We will continue to drive growth in the bio-healthcare industry through professional knowledge-sharing and continuous technological innovation. Thank you.